Promising Outlook for Olema Pharmaceuticals’ Palazestrant: Buy Rating Backed by Robust Clinical Results and High Potential for Successful OPERA-01 Trial

Nvidia CEO aiming to set up base in Vietnam, Reuters reports

Utz Brands to host investor day

Updated Odronextamab Data from Relapsed/Refractory Diffuse Large B-cell Lymphoma Pivotal Trial Showed Deep and Durable Responses and the Potential of ctDNA To Predict Long-term...

Jasper Therapeutics Presents Positive Final Results from Phase 1 Study of Briquilimab in Patients with AML or MDS Undergoing Hematopoietic Cell Transplant in Oral...